DocGo (DCGO) Change In Receivables : $-158.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is DocGo Change In Receivables?

DocGo's change in receivables for the quarter that ended in Mar. 2024 was $-22.4 Mil. It means DocGo's Accounts Receivable increased by $22.4 Mil from Dec. 2023 to Mar. 2024 .

DocGo's change in receivables for the fiscal year that ended in Dec. 2023 was $-160.5 Mil. It means DocGo's Accounts Receivable increased by $160.5 Mil from Dec. 2022 to Dec. 2023 .

DocGo's Accounts Receivable for the quarter that ended in Mar. 2024 was $283.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. DocGo's Days Sales Outstanding for the three months ended in Mar. 2024 was 134.50.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. DocGo's liquidation value for the three months ended in Mar. 2024 was $78.0 Mil.

DocGo Change In Receivables Historical Data

The historical data trend for DocGo's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocGo Change In Receivables Chart

DocGo Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-2.28

-16.15

-58.00

-8.42

-160.53

DocGo Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial												-24.67	9.26	-88.08	-57.04	-22.40

DocGo Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-158.3 Mil.

DocGo (NAS:DCGO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

DocGo's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	283.127	/	192.088	*	91
=	134.50

2. In Ben Graham's calculation of liquidation value, DocGo's accounts receivable are only considered to be worth 75% of book value:

DocGo's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	41.244	-	175.609	+	0.75 * 283.127	+	0.5 * 0
=	78.0

DocGo Change In Receivables Related Terms

Thank you for viewing the detailed overview of DocGo's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

DocGo (DCGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocGo Inc (NAS:DCGO) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 West 35th Street, Floor 6, New York, NY, USA, 10001

Website

https://www.docgo.com

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. DocGo is disrupting the traditional four-wall healthcare system by providing care at the scale of humanity. Its technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace.

Executives

Stephen Sugrue	officer: Chief Compliance Officer	35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Lee Bienstock	officer: Chief Operating Officer	35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Ely D Tendler	director, officer: General Counsel, Secretary	STRATEGIC AND LEGAL SERVICES, PLLC, 54 LAWRENCE AVENUE, LAWRENCE NY 11559
Anthony Capone	officer: President	106 DUANE ST., #3, NEW YORK NY 10007
Adriaan Stephanus Oberholzer	officer: Chief Financial Officer	35 W 35TH STREET, 6TH FLOOR, NEW YORK NY 10001
James M Travers	director	C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Etalvina Leite	director	5477 VIA NICOLA, NEWBURY PARK CA 91320
Michael J Burdiek	director	39 PARKER, IRVINE CA 92618
Ira Smedra	director	401 N. JUNE STREET, LOS ANGELES CA 90004
Mark Do Merlin	officer: CMO, Ambulnz Holdings, LLC	35 W 35TH STREET, NEW YORK NY 10001
Michael S. Witkowski	officer: Chief Compliance Officer	PO BOX 10482, NEWBURGH NY 12552
Christopher Fillo	director	3110 MAIN STREET, SUITE 310, SANTA MONICA CA 90405
Norman Rosenberg	officer: CFO, Ambulnz Holdings, LLC	51 MOUNTAIN AVENUE, MONSEY NY 10952
Stanley Vashovsky	director, 10 percent owner, officer: Chief Executive Officer	763 RALEIGH STREET, WOODMERE NY 11598
Steven Katz	director	20 REBEL RUN DR, EAST BRUNSWICK NJ 08816